BACKGROUND: Despite accessible diagnostics and treatment of hypertension, a high proportion of patients worldwide remain unaware of their diagnosis, and even more remain untreated. Several studies suggest that absence of comorbidities is a predictive factor for unawareness and consequently non-treatment of hypertension. There are only a few studies that have assessed the hypertension prevalence and management among apparently healthy individuals. OBJECTIVE: The aim of the study was to assess and compare hypertension prevalence, awareness, treatment and control among apparently healthy individuals, patients with internal diseases, and patients with non-internal diseases. METHODS: Data from standardised blood pressure measurements conducted during the Czech European Health Examination Survey 2014 and information on health status and health care use collected during the Czech European Health Interview Survey 2014 were analyzed. We focused on participants aged 25-64. Data were weighted on sex and age to ensure an appropriate sex and age structure of the population. The χ2-test and binary logistic regression analyses were used to compare distribution of cascade of care for hypertension between the health-status groups of respondents. RESULTS: The final eligible sample consisted of 1121 participants. The prevalence of hypertension was 32.8% in the healthy group, 29.8% in the non-internal disease group and 52.4% in the internal disease group, (p < 0.001). Awareness was 54.1%, 59.1% and 85.2% respectively, (p < 0.001). Treatment was 44.2%, 52.6% and 86.4%, respectively, (p < 0.001). Among apparently healthy respondents 62.6% had their blood pressure measured by a medical professional in the last year, compared to 71.1% in the non-internal disease group and 91.7% in the internal disease group, (p < 0.001). Differences in hypertension control were not statistically significant. CONCLUSIONS: Generally, our data show a discordance in hypertension management within the Czech population. Apparently healthy individuals are the least aware of their diagnosis and the highest proportion of them remain untreated.

Department of Cardiology University Hospital Motol 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Internal Medicine University Hospital Královské Vinohrady 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Internal Medicine University Hospital Motol 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Public Health Faculty of Medicine Masaryk University Brno Czech Republic

Department of Social Geography and Regional Development Faculty of Science Charles University Prague Czech Republic

Departments of Global Health and Population and Epidemiology Harvard TH Chan School of Public Health Harvard University Boston Massachusetts United States of America

Foundation for Clinic Public Health and Epidemiology Research of Venezuela Caracas Venezuela

International Clinical Research Centre Brno Czech Republic

National Institute of Public Health Prague Czech Republic

Zobrazit více v PubMed

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi: 10.1038/s41581-019-0244-2 PubMed DOI PMC

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi: 10.1016/S0140-6736(21)01330-1 PubMed DOI PMC

World health organization. The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Accessed September 14, 2021.

GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019 Jun 22;393(10190):e44] [published correction appears in Lancet. 2018 Nov 17;392(10160):2170]. Lancet. 2018;392(10159):1736–1788. doi: 10.1016/S0140-6736(18)32203-7 PubMed DOI PMC

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [published correction appears in Lancet. 2003 Mar 22;361(9362):1060]. Lancet. 2002;360(9349):1903–1913. doi: 10.1016/s0140-6736(02)11911-8 PubMed DOI

Čapková N, Lustigová M, Kratěnová J, Žejglicová K, Zdravotní stav české populace: výsledky studie EHES 2014. Praha: Státní zdravotní ústav, 2016. ISBN 978-80-7071-356-3.

Ettehad D, Emdin CA, Kiran A, Anderson S, Callender T, Emberson J, et al.. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi: 10.1016/S0140-6736(15)01225-8 PubMed DOI

Tolonen H, Giampaoli S, Kuulasmaa K, Mindell J, Mannisto S, Dias C, et al.. Blood pressure profiles, and awareness and treatment of hypertension in Europe—results from the EHES Pilot Project. Public Health. 2016;135:135–139. doi: 10.1016/j.puhe.2015.10.035 PubMed DOI

Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, et al.. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. PLoS One. 2020;15(5):e0232845. Published 2020 May 11. doi: 10.1371/journal.pone.0232845 PubMed DOI PMC

Soliman SSA, Guseman EH, Haile ZT, Ice G. Prevalence and determinants of hypertension unawareness among Egyptian adults: the 2015 EHIS. J Hum Hypertens. 2021;35(10):927–934. doi: 10.1038/s41371-020-00431-1 PubMed DOI

Fenech G, Vallée A, Cherfan M, Kab S, Goldberg M, Zins M, et al.. Poor Awareness of Hypertension in France: The CONSTANCES Population-Based Study. Am J Hypertens. 2020;33(6):543–551. doi: 10.1093/ajh/hpaa018 PubMed DOI

Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechère-Bertschi A. 1999–2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One. 2012;7(6):e39877. doi: 10.1371/journal.pone.0039877 PubMed DOI PMC

Roomi MA, Mohammadnezhad M. Prevalence Of Metabolic Syndrome Among Apparently Healthy Workforce. J Ayub Med Coll Abbottabad. 2019;31(2):252–254. PubMed

Elkhalifa AM, Kinsara AJ, Almadani DA. Prevalence of hypertension in a population of healthy individuals. Med Princ Pract. 2011;20(2):152–155. doi: 10.1159/000321217 PubMed DOI

European Health Interview Survey (EHIS). Available at: https://ec.europa.eu/eurostat/web/microdata/european-health-interview survey; 2019. Accessed September 17, 2021

Brož J, Malinovská J, Nunes MA, Kučera K, Rožeková K, Žejglicová K, et al.. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract. 2020;170:108470. doi: 10.1016/j.diabres.2020.108470 PubMed DOI

Widimský J. jr., Filipovský J, Ceral J, Cífková R, Linhart A, Petrák O, et al.., Diagnostické a léčebné postupy u arteriální hypertenze ČSH 2022. Hypertenze a kardiovaskulární prevence. 2022; 1805–4129.

National institute of public health. The Czech EHES study manual. Available at: https://szu.cz/wp-content/uploads/2023/01/manual_EHES_cely_28042014.pdf

Vejtasová V, Lustigová M, Urbanová J, Žejglicová K, Malinovská J, Janíčková Žďárská D, et al.. Prevalence and management of arterial hypertension in the population aged 25–64 in the Czech Republic with a focus on diabetic patients. Epidemiol Mikrobiol Imunol. 2021. Winter;70(4):247–252. English. PubMed

Wozniak G, Khan T, Gillespie C, Sifuentes L, Hasan O, Ritchey M, et al.. Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control. J Clin Hypertens (Greenwich). 2016;18(3):232–239. doi: 10.1111/jch.12654 PubMed DOI PMC

Vyhláška o preventivních prohlídkách, Vyhláška č. 70/2012 Sb. Available at: https://www.zakonyprolidi.cz/cs/2012-70; Accessed October 20, 2021

Baker R, Wilson A, Nockels K, Agarwal S, Modi P, Bankart J. Levels of detection of hypertension in primary medical care and interventions to improve detection: a systematic review of the evidence since 2000. BMJ Open. 2018;8(3):e019965. Published 2018 Mar 22. doi: 10.1136/bmjopen-2017-019965 PubMed DOI PMC

Filippi A, Degli Esposti L, Buda S, Diguardo A, Paolini I, Nati G. Why is my hypertensive patient still not controlled? High Blood Press Cardiovasc Prev. 2015; 22(1): 69–72. doi: 10.1007/s40292-014-0075-y PubMed DOI

Lu W, Pikhart H, Tamosiunas A, Kubinova R, Capkova N, Malyutina S, et al.. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study. BMC Public Health. 2022;22(1):883. Published 2022 May 4. doi: 10.1186/s12889-022-13260-3 PubMed DOI PMC

Van Loon AJM, Tijhuis M, Picavet HSJ, Surtees PG, Ormel J. Survey non-response in the Netherlands: effects on prevalence estimates and associations. Ann Epidemiol 2003;13(2):105–10. doi: 10.1016/s1047-2797(02)00257-0 PubMed DOI

Suominen S, Koskenvuo K, Sillanmaki L, Vahtera J, Korkeila K, Kivimäki M, et al.. Non-response in a nationwide follow-up postal survey in Finland: a register based mortality analysis of respondents and nonrespondents of the Health and Social Support (HeSSup) Study. BMJ Open 2012;2012(2). 10.1136/bmjopen-2011-000657 e000657. PubMed DOI PMC

Eriksen L, Gronbak M, Helge JW, Tolstrup JS, Curtis T. The Danish Health Examination Survey 2007–2008 (DANHES 2007–2008). Scand J Public Health 2011;39(2):203–11. doi: 10.1177/1403494810393557 PubMed DOI

Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, Torén K, et al.. Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 2010;25(3):163–72. doi: 10.1007/s10654-010-9427-7 PubMed DOI